In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
Keep Reading →
March 9 - News
Royalty Pharma plc beats earnings expectations. Reported EPS is $1.15, expectations were $1.01.
Keep Reading →
February 16 - News, Transcripts
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter.
Keep Reading →
January 31 - Hedge Fund Investor Letters, News
In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds.
Keep Reading →
December 27 - Hedge Funds, News
In this article, we discuss the 5 most promising healthcare stocks according to analysts.
Keep Reading →
December 19 - Hedge Funds, News
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter.
Keep Reading →
December 18 - Hedge Fund Investor Letters, News
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
Keep Reading →
December 15 - Hedge Funds, News
In this article, we will take a look at 5 stocks with 50% upside potential according to analysts.
Keep Reading →
December 11 - News
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2023 Earnings Conference Call.
Keep Reading →
November 9 - News, Transcripts
The inflation storm and subsequent rate hikes by the Federal Reserve have left investors on the back foot as a strange skepticism has taken over the market.
Keep Reading →
September 24 - Hedge Funds, News
In this article, we discuss 12 biotech stocks with biggest upside.
Keep Reading →
September 9 - Hedge Funds, News
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma second quarter earnings conference call.
Keep Reading →
August 10 - News, Transcripts
In this article, we discuss 15 worst performing biotech stocks in 2023.
Keep Reading →
August 8 - Hedge Funds, News, Stock Analysis
In this article, we will take a look at the 10 stocks that are seeing significant buy-side insider activity.
Keep Reading →
June 2 - Hedge Funds, Insider Trading, News
Berkshire Hathaway, headed by Warren Buffett, sold $13.3 billion worth of stock in the first quarter of 2023 while investing only a fraction of that amount in US equities.
Keep Reading →
May 21 - Business, Hedge Funds, News
In this article, we will take a look at the 10 large-cap stocks with insider buying.
Keep Reading →
May 20 - Insider Trading, News
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma First Quarter Earnings Conference Call.
Keep Reading →
May 10 - News, Transcripts
In this article, we will take a look at the 5 most promising healthcare stocks according to analysts.
Keep Reading →
March 29 - Hedge Funds, News
In this article, we discuss companies that just started paying dividends.
Keep Reading →
March 2 - Dividend Stocks, Hedge Funds, News
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Fourth Quarter Earnings Conference Call.
Keep Reading →
February 16 - News, Transcripts
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter Earnings Conference Call.
Keep Reading →
December 29 - News, Transcripts
Alongside the United States, Europe has some of the most advanced industries and economies in the world.
Keep Reading →
November 23 - Lists, News
In this piece, we’ll take a look at the 5 Best Blue Chip Stocks to Buy According to Phill Gross and Robert Atchinson's Adage Capital.
Keep Reading →
September 23 - Hedge Funds, News
In this article, we discuss the 3 stocks that Warren Buffett is decreasing stakes in.
Keep Reading →
September 6 - Hedge Funds, News
In this article, we discuss the dividend stocks to buy according to Andreas Halvorsen's Viking Global.
Keep Reading →
May 25 - Hedge Funds, News
Billionaire hedge fund manager Bill Ackman asserted on Tuesday that the United States Federal Reserve needs to tackle inflation in an aggressive manner or face a market crash ...
Keep Reading →
May 24 - Hedge Funds, Insider Trading
In this article, we discuss 3 stocks that Warren Buffett is selling in 2022.
Keep Reading →
May 20 - Hedge Funds, News
In this article, we discuss the 5 best dividend stocks according to Andreas Halvorsen's Viking Global.
Keep Reading →
February 19 - Hedge Funds, News
In this article, we discuss the 10 stocks that Warren Buffett is selling.
Keep Reading →
February 18 - Hedge Funds, News
In this article, we discuss 10 best healthcare stocks to buy in 2022.
Keep Reading →
February 14 - Hedge Funds, News
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Keep Reading →
October 26 - Hedge Funds, News
In this article, we discuss the top 5 picks in Harvard University's Stock portfolio.
Keep Reading →
October 11 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
July 13 - Hedge Funds, News
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Keep Reading →
April 21 - Hedge Funds, News
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Keep Reading →
April 21 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
December 17 - Hedge Funds, News
Waratah Capital Advisors has launched the firm's second liquid alternative mutual fund, the Waratah Alternative ESG (AESG) Fund.
Keep Reading →
June 29 - Hedge Funds, Insider Trading
It's profit taking day for many investors, as all three major indexes are modestly lower. In late-afternoon trading, both the Dow and the S&P are off by 0.24%, while the Nasdaq...
Keep Reading →
September 8 - Market Movers, News
Repros Therapeutics Inc (NASDAQ:RPRX) just put out data from its phase II in moderate to severe endometriosis, and the company has gained close to 17% on the data.
Keep Reading →
September 8 - News, Stock Analysis
Although all three indexes are well in the green and the Dow Jones is above 18,000 with this quarter's earnings season being relatively quiet and the results less dire than had...
Keep Reading →
April 20 - Market Movers, News
After the OPEC countries participating in the Doha meeting this weekend failed to reach a deal to limit oil production, crude prices fell heavily on Monday.
Keep Reading →
April 18 - Market Movers, News
With earnings season now in full swing, the Dow and S&P 500 are each slightly in the red as investors weigh various bits of macro-economic data and different earnings reports.
Keep Reading →
April 14 - Market Movers, News
Shares of Repros Therapeutics Inc (NASDAQ:RPRX) ended up by 45.14% during today's truncated Black Friday trading session, following the Thanksgiving holiday.
Keep Reading →
November 27 - Hedge Funds, Market Movers, News
RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX).
Keep Reading →
March 19 - Hedge Funds, News
Insider buying activity has been shown to generate annual outperformance of about 7 percentage points, according to multiple empirical studies.
Keep Reading →
October 21 - Insider Trading, News
Repros Therapeutics new drug: Insider Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), purchased 1,000 shares of common stock last week at...
Keep Reading →
October 14 - Insider Trading, News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
September 17 - News
At the moment, there are tons of metrics shareholders can use to monitor their holdings. A couple of the most under-the-radar are hedge fund and insider trading sentiment.
Keep Reading →
September 12 - News